These results tend to support the hypothesis that SGLT2 inhibition can ameliorate kidney oxygenation in diabetes essentially through the inhibition of the diabetes-induced hyper-reabsorption of glucose and sodium cotransport in the renal proximal tubule, a high oxygen demanding transport system. This evidence concerns the gene SLC5A2 and diabetes mellitus.